These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6270707)

  • 1. Plasma viscosity: relation to age, atherogenic diet and suloctidil.
    Amico-Roxas M; Drago F; Canonico PL; Russo A; Terranova R; Spitaleri A; Bianchi A
    Pharmacol Res Commun; 1981 Sep; 13(8):765-7. PubMed ID: 6270707
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of suloctidil on plasma viscosity in rats on an atherogenic diet].
    Drago F; Amico-Roxas M; Russo A; Bianchi A; Mazzoleni G
    Farmaco Prat; 1980 Aug; 35(8):423-6. PubMed ID: 6256204
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of suloctidil on blood viscosity in healthy volunteers after forearm occlusion.
    Drago F; Canonico PL; Amico-Roxas M
    Experientia; 1981 Oct; 37(10):1095-6. PubMed ID: 6273209
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of suloctidil on cerebral circulation patterns of conscious rabbits.
    Rozza Dionigi A; Lanza E; Favalli L; Carminati GM; Piccinini F
    Arzneimittelforschung; 1986 Feb; 36(2):194-6. PubMed ID: 3008769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of suloctidil on the central and peripheral nervous systems].
    Nishi H; Watanabe T; Mori M
    Nihon Yakurigaku Zasshi; 1983 Sep; 82(3):191-212. PubMed ID: 6319248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of suloctidil on dopaminergic transmission in various rat brain areas: possible uses as drug for the elderly.
    Montefusco O; Missale C; Govoni S; Rozzini R; Trabucchi M
    Pharmacol Res Commun; 1983 Mar; 15(3):317-27. PubMed ID: 6304786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic activity of suloctidil.
    Roba J; Defreyn G; Biagi G
    Thromb Res Suppl; 1983; 4():53-8. PubMed ID: 6314585
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of long-term treatment with suloctidil on blood viscosity, erythrocyte deformability and total fibrinogen plasma levels in diabetic patients.
    Roncucci R; De Hertogh R; Dormandy JA; Doumont J; Gurewich V; Lambelin G; Lansen J; Rottiers R; Souridis E; Van Stalle F; Versee L
    Arzneimittelforschung; 1979; 29(4):682-4. PubMed ID: 582768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suloctidil: long-term trial in the aged. Study of microcirculation, viscosity, red cell deformability, fibrinolysis and lipid fractions.
    Merchan R; Zurita IE; Martinez JF
    Arzneimittelforschung; 1985; 35(5):855-7. PubMed ID: 2992530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Suloctidil decreases the serotonin concentration in the brain stem of rats with a portacaval shunt].
    Valenzuela Miranda C; Aller Reyero MA; Arias Pérez J; Alsasua del Valle A; Arias Pérez JL; Rodríguez Sánchez JC; Durán Sacristán H
    Rev Esp Enferm Apar Dig; 1988 May; 73(5 Pt 2):547-52. PubMed ID: 2845525
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of suloctidil on Na+/K+ ATPase activity and on membrane fluidity in rat brain synaptosomes.
    Chatelain P; Reckinger N; Roncucci R
    Biochem Pharmacol; 1979 Dec; 28(24):3677-80. PubMed ID: 231452
    [No Abstract]   [Full Text] [Related]  

  • 12. Suloctidil increases the rat brain cortex microvascular regeneration after a lesion.
    De Paermentier F; Heuschling P; Knoops B; Janssens De Varebeke P; Pauwels G; Laszlo De Kaszon-Jakabfalva C; Van den Bosch De Aguilar P
    Life Sci; 1989; 44(1):41-7. PubMed ID: 2464117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Ca-movement and mechanical movement in rabbit taenia coli by a smooth muscle relaxant (suloctidil).
    Takayanagi I; Koike K; Yoshida Y; Kaneko M
    J Pharmacobiodyn; 1981 Oct; 4(10):798-802. PubMed ID: 6119359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suloctidil-phospholipid interaction in bilayer membranes: effects on lipid dynamics.
    Chatelain P; Ruysschaert JM
    Biochem Pharmacol; 1981 Feb; 30(4):313-7. PubMed ID: 6260117
    [No Abstract]   [Full Text] [Related]  

  • 15. Suloctidil treatment prevents the development of post-traumatic feline spinal cord ischemia.
    Wolf DL; Hall ED
    Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):139-44. PubMed ID: 2990364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by suloctidil of [3H] nitrendipine binding to cerebral cortex membranes.
    Chatelain P; Demol D; Roba J
    Biochem Pharmacol; 1984 Apr; 33(7):1099-103. PubMed ID: 6324812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of prostacyclin production in blood vessels by the antithrombotic drug suloctidil.
    Boeynaems JM; Van Coevorden A; Demolle D
    Biochem Pharmacol; 1987 May; 36(10):1629-35. PubMed ID: 3036152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro vasorelaxing activity of suloctidil.
    Calderon P; van Dorsser W; Geöcze von Szendroi K; De Mey JG; Roba J
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):101-13. PubMed ID: 3030204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of platelet thromboxane generation by suloctidil in man.
    Bucchi F; Cerletti C; de Gaetano G
    Haemostasis; 1986; 16(5):362-8. PubMed ID: 3023210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of suloctidil on the dynamics of the peripheral artery of the dog].
    Horii D; Ishibashi A; Sano F
    Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):67-78. PubMed ID: 6311700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.